Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Research and development | 3M | 13M | 9M | 7M |
| Selling, general and administrative | 4M | 6M | 8M | 9M |
| Operating income | −7M | −18M | −17M | −16M |
| Interest expense | 3,000 | 32,000 | 9,000 | 43,000 |
| Pre-tax income | −7M | −86M | −123M | −15M |
| Income tax | −3,000 | −11M | −18M | 4M |
| Net income | −7M | −75M | −105M | −19M |
| Earnings per share | −5.72 | −77.83 | −129.79 | −1.29 |
| Earnings per share, diluted | −5.72 | −77.83 | −129.79 | −1.29 |
| Weighted average shares | 1M | 968,000 | 806,000 | 13M |
| Metric | 18/08/2026 | 31/07/2025 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | 600,000 | 2M | 5M | 11M | 23M | 3M |
| Receivables | — | — | 555,000 | 3M |
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Operating cash flow | −5M | −14M | −12M | −7M |
| Depreciation and amortisation | 35,000 | 54,000 | 1,000 | — |
| Share-based compensation | 321,000 | 3M | 4M | 9M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 3M |
| — |
| — |
| Current assets | — | — | 2M | 8M | 14M | — | — |
| Total assets | — | — | 2M | 8M | 99M | — | — |
| Current liabilities | — | — | 1M | 3M | 2M | — | — |
| Total liabilities | — | — | 3M | 4M | 24M | — | — |
| Equity | — | — | −827,000 | 3M | 75M | 165M | 148M |
| Capital expenditure |
| — |
| — |
| 3,000 |
| — |
| Investing cash flow | — | 3M | −617,000 | — |
| Financing cash flow | 2M | 6M | −117,000 | 27M |